SMS Pharmaceuticals Share Price
392.65+18.50 (+4.94%)
+67.92% past 1 Year
News
SMS Pharmaceuticals Q1 EBITDA and margin improve on year-on-year basis
Equity
SMSPHARMA
SMS Pharmaceuticals posts year-on-year revenue growth in Q1 FY2026 results
Equity
SMSPHARMA
SMS Pharmaceuticals Q1 standalone net profit rises year-on-year to Rs 21.10 crores
Equity
SMSPHARMA
SMS Pharmaceuticals - Quaterly Results
Equity
SMSPHARMA
SMS Pharmaceuticals reports Profit after tax of 20.92 Crores, in the March 2026 quarter
Equity
SMSPHARMA
SMS Pharmaceuticals Q4 EBITDA broadly flat YoY with stable margin profile
Equity
SMSPHARMA
SMS Pharma Q4 revenue declines year-on-year, signals softer topline performance
Equity
SMSPHARMA
Sms Pharma reports steady Q4 standalone net profit growth
Equity
SMSPHARMA
SMS Pharmaceuticals informs about board meeting
Equity
SMSPHARMA
SMS Pharmaceuticals informs about newspaper publication
Equity
SMSPHARMA
SMS Pharmaceuticals informs about compliance certificate
Equity
SMSPHARMA
SMS Pharmaceuticals informs about trading window closure
Equity
SMSPHARMA
SMS Pharmaceuticals informs about newspaper publication
Equity
SMSPHARMA
SMS Pharmaceuticals reports Profit after tax of 23.34 Crores, in the December 2025 quarter
Equity
SMSPHARMA
SMS Pharmaceuticals Q3 FY26 EBITDA Rises 31.5% YoY to Rs 43.80 Crores, Margin Expands to 20.81%.
Equity
SMSPHARMA
SMS Pharmaceuticals Q3 FY26 Results: Net Profit up 35% YoY to Rs 23.30 Crores, Revenue up 21% to Rs 210 Crores.
Equity
SMSPHARMA
SMS Pharma raises stake in subsidiary SMS Peptides to 99.99 percent via share issue
Equity
SMSPHARMA
SMS Pharmaceuticals forms new wholly owned unit SMS coLab Private Limited
Equity
SMSPHARMA
USFDA completes inspection at SMS Pharmaceuticals’ API manufacturing facility at Visakhapatnam
Equity
SMSPHARMA
SMS Pharma clears USFDA inspection at Vizag facility with minor Form 483
Equity
SMSPHARMA